England - London • Corporate and commercial
Bristows LLP
The 'user friendly' team at Bristows LLP provides 'outcomes focused and sensible' advice for corporate venture arms, institutional investors and university-spin outs providing and seeking investment within the life sciences and tech sectors, in particular. Marek Petecki is key to the firm's success in the area and provides 'considered and thoughtful advice' throughout the funding life cycle. check Iain Redford heads the team and handles some venture capital work as an extension of his broader corporate finance, private equity and M&A offering.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'The team is personable, responsive and thoughtful.'
- 'The team is user friendly, outcomes focused and sensible.'
- 'Marek Petecki is considered and thoughtful, humble, engaged, creative and direct.'
- 'Marek Petecki - very user friendly and all round great chap.'
- 'Sam Munday is a strong associate.'
Key clients
- Diageo
- Syncona
- Johnson & Johnson Innovations
- Braavos Capital
- Oxford Science Enterprises plc
- UCL Business
- Francis Crick Institute
- IP Group plc
- Oxehealth
- OMass Therapeutics
- Purespring Therapeutics
- Mosaic Therapeutics
- LifeArc
- Orca Computing
- Neu Health Digital Ltd
- Ēvolvere Biosciences Ltd
- FundamentalVR
Work highlights
- Advised OMass Therapeutics on its $100m Series B financing.
- Advised lead investors Syncona and Cambridge Innovation Capital on the spin-out of Mosaic Therapeutics from the Wellcome Sanger Institute and associated $28m Series A funding round.
- Advised FundamentalVR on its $20m Series B funding.
Practice head
The lawyer(s) leading their teams.
Iain Redford